戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 a diagnostic criterion and can be applied to neonatal screening.
2 trategies for sickle cell disease, including neonatal screening.
3 ls to assess the effectiveness and safety of neonatal screening and early treatment.
4  blood spot samples obtained from the Danish Neonatal Screening Biobank and genotyped using the Illum
5 d individuals were retrieved from the Danish Neonatal Screening Biobank.
6 zation, and DNA was obtained from the Danish Neonatal Screening Biobank.
7             DNA was obtained from the Danish Neonatal Screening Biobank.
8                                              Neonatal screening for CAH and gene-specific prenatal di
9                                  We assessed neonatal screening for CAH from January 1, 1986, through
10       As a result of such screening efforts, neonatal screening for CAH has proven to be highly relia
11 nt reports have questioned the rationale for neonatal screening for congenital adrenal hyperplasia (C
12     Consideration must be given to universal neonatal screening for cytomegalovirus to facilitate ear
13                   We reviewed the results of neonatal screening for homocystinuria over a period of 3
14                                              Neonatal screening for SCID would significantly improve
15                                These include neonatal screening of immunodeficiencies and asthma biom
16  patients with cystic fibrosis identified by neonatal screening or by standard diagnostic methods.
17             In CF patients diagnosed through neonatal screening, P aeruginosa pulmonary infections oc
18 e facilitated the introduction of nationwide neonatal screening programmes for a large number of meta
19 ren necessitates implementation of universal neonatal screening programmes for hearing impairment.
20                                              Neonatal screening programmes, based on clinical screeni
21 s, stem cell transplantation facilities, and neonatal screening programs.
22 a detected in tandem mass spectrometry-based neonatal screening programs.
23                             The Wisconsin CF Neonatal Screening Project is a longitudinal investigati
24 n and treatment protocol of the Wisconsin CF Neonatal Screening Project.
25                                  Although CF neonatal screening provides a potential opportunity for
26                                              Neonatal screening provides the opportunity to prevent m
27 ic categories: meconium ileus (MI), prenatal/neonatal screening (SCREEN), positive family history (FH
28 or blood methionine of 1 mg per deciliter in neonatal screening tests for homocystinuria should ident
29 infection as well as the lack of large-scale neonatal screening tools.

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。